Skip to main content
OpenTrials

Clinical trial condition

Hair Diseases

Explore clinical trials studying Hair Diseases. Study availability and eligibility vary by location and protocol.

493 public trials 79 recruiting studies
Refine in advanced search Browse all conditions

Hair Diseases trial results

Active, Not Recruiting

A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)

NCT06799520

Conditions
Alopecia, Alopecia Areata, Alopecia Areata (AA), +10 more
Locations
  • Visterra Investigational Site Sofia, Bulgaria
  • Visterra Investigational Site Chisinau, Moldova
  • Visterra Investigational Site Bucharest, Romania
  • Visterra Investigational Site Cluj-Napoca, Romania
View Trial Details
Active, Not Recruiting

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)

NCT06340360

Conditions
Alopecia, Alopecia Areata, Hair Diseases, +3 more
Locations
  • Nektar Investigative Site Northridge, California, United States
  • Nektar Investigative Site Atlanta, Georgia, United States
  • Nektar Investigative Site Gurnee, Illinois, United States
  • Nektar Investigative Site Indianapolis, Indiana, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations
  • RTI International Research Triangle Park, North Carolina, United States
View Trial Details
Active, Not Recruiting

A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

NCT07029711

Conditions
Alopecia, Alopecia Areata, Hair Diseases, +4 more
Locations
  • UCI Dermatology Clinical Research Irvine, California, United States
  • Southern California Clinical Research Santa Ana, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 80 locations
View Trial Details
Active, Not Recruiting

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

NCT06018428

Conditions
Alopecia, Alopecia Areata, Dermatitis, +6 more
Locations
  • Scottsdale, Arizona Scottsdale, Arizona, United States
  • Fayetteville, Arkansas Fayetteville, Arkansas, United States
  • Hot Springs, Arkansas Hot Springs, Arkansas, United States
  • Encinitas, California Encinitas, California, United States
View all 33 locations
View Trial Details

Related conditions